The Locator -- [(subject = "POLITICAL SCIENCE / Public Policy / General")]

54 records matched your query       


Record 38 | Previous Record | MARC Display | Next Record | Search Results
Author:
Abraham, John, 1961- author. http://id.loc.gov/authorities/names/n00003890
Title:
Unhealthy pharmaceutical regulation : innovation, politics and promissory science / Courtney Davis, Kings College London, UK and John Abraham, Kings College London, UK.
Publisher:
Palgrave Macmillan,
Copyright Date:
2013
Description:
xii, 321 pages ; 23 cm.
Subject:
Pharmaceutical policy--United States.
Pharmaceutical policy--European Union countries.
Drugs--Law and legislation--United States.
Drugs--Law and legislation--European Union countries.
Pharmaceutical industry--Political aspects.
SOCIAL SCIENCE / Sociology / General.
SOCIAL SCIENCE / Disease & Health Issues.
POLITICAL SCIENCE / Public Policy / General.
MEDICAL / Health Policy.
MEDICAL / Pharmacy.
Other Authors:
Davis, Courtney, 1965- author. http://id.loc.gov/authorities/names/nb2011008437
Notes:
Includes bibliographical references and index.
Contents:
Machine generated contents note: -- Introduction * Innovation, Therapeutic Progress and Regulation * The Regulatory Culture of Accelerated Drug Development and Review * Regulatory and Scientific Standards * Reshaping the Evidence-Base * Risk Management Versus Market Withdrawal * Rapid Regulatory Review, Pharmaceutical Innovation and Public Health * Transparency, Public Accountability and Meeting Patients' Needs * Conclusion * References/Bibliography * Index.
Summary:
"European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health. "-- Provided by publisher.
Series:
Health, technology and society
ISBN:
0230008666
9780230008663
OCLC:
(OCoLC)144227252
LCCN:
2013021799
Locations:
OVUX522 -- University of Iowa Libraries (Iowa City)

Initiate Another SILO Locator Search

This resource is supported by the Institute of Museum and Library Services under the provisions of the Library Services and Technology Act as administered by State Library of Iowa.